JPS5050383A - - Google Patents

Info

Publication number
JPS5050383A
JPS5050383A JP10056073A JP10056073A JPS5050383A JP S5050383 A JPS5050383 A JP S5050383A JP 10056073 A JP10056073 A JP 10056073A JP 10056073 A JP10056073 A JP 10056073A JP S5050383 A JPS5050383 A JP S5050383A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10056073A
Other languages
Japanese (ja)
Other versions
JPS525517B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP10056073A priority Critical patent/JPS525517B2/ja
Publication of JPS5050383A publication Critical patent/JPS5050383A/ja
Publication of JPS525517B2 publication Critical patent/JPS525517B2/ja
Expired legal-status Critical Current

Links

JP10056073A 1973-09-05 1973-09-05 Expired JPS525517B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10056073A JPS525517B2 (en) 1973-09-05 1973-09-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10056073A JPS525517B2 (en) 1973-09-05 1973-09-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP51062655A Division JPS51146482A (en) 1976-05-28 1976-05-28 Process for preparing n1-(2- tetrahydrofuryl)-5-fluorouracil

Publications (2)

Publication Number Publication Date
JPS5050383A true JPS5050383A (en) 1975-05-06
JPS525517B2 JPS525517B2 (en) 1977-02-14

Family

ID=14277299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10056073A Expired JPS525517B2 (en) 1973-09-05 1973-09-05

Country Status (1)

Country Link
JP (1) JPS525517B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51146482A (en) * 1976-05-28 1976-12-16 Taiho Yakuhin Kogyo Kk Process for preparing n1-(2- tetrahydrofuryl)-5-fluorouracil
DE2650918A1 (en) * 1975-11-10 1977-05-26 Asahi Chemical Ind Anticancer (N-2)-furanidyl-(5)-fluoro-uracil prepn. - by reacting bis-trialkylsilyl (5)-fluoro uracil with (2,3)-dihydro-furan
JPS5268189A (en) * 1975-12-04 1977-06-06 Rikagaku Kenkyusho Preparation of pyrimidine-type nucleosides
JPS5268190A (en) * 1976-05-11 1977-06-06 Rikagaku Kenkyusho Preparation of pyrimidine-type nucleosides
US7879816B2 (en) 2005-06-07 2011-02-01 Yale University Methods of treating cancer and other conditions or disease states using LFMAU and LDT
US7951788B2 (en) 2005-12-02 2011-05-31 Yale University Method of treating cancer and other conditions or disease states using L-cytosine nucleoside analogs
EP2390257A1 (en) 1998-02-25 2011-11-30 Emory University 2'-fluoronucleosides
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
CN110655507A (en) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 Preparation method of antineoplastic drug tegafur

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650918A1 (en) * 1975-11-10 1977-05-26 Asahi Chemical Ind Anticancer (N-2)-furanidyl-(5)-fluoro-uracil prepn. - by reacting bis-trialkylsilyl (5)-fluoro uracil with (2,3)-dihydro-furan
DE2650918C2 (en) * 1975-11-10 1983-06-09 Asahi Kasei Kogyo K.K., Osaka Process for the preparation of N? 1? - (2-tetrahydrofuranyl) -5-fluoro-uracil
JPS5268189A (en) * 1975-12-04 1977-06-06 Rikagaku Kenkyusho Preparation of pyrimidine-type nucleosides
JPS5337873B2 (en) * 1975-12-04 1978-10-12
JPS5268190A (en) * 1976-05-11 1977-06-06 Rikagaku Kenkyusho Preparation of pyrimidine-type nucleosides
JPS5337874B2 (en) * 1976-05-11 1978-10-12
JPS5412475B2 (en) * 1976-05-28 1979-05-23
JPS51146482A (en) * 1976-05-28 1976-12-16 Taiho Yakuhin Kogyo Kk Process for preparing n1-(2- tetrahydrofuryl)-5-fluorouracil
EP2390257A1 (en) 1998-02-25 2011-11-30 Emory University 2'-fluoronucleosides
EP2392580A1 (en) 1998-02-25 2011-12-07 Emory University 2'-fluoronucleosides
US7879816B2 (en) 2005-06-07 2011-02-01 Yale University Methods of treating cancer and other conditions or disease states using LFMAU and LDT
US8207143B2 (en) 2005-06-07 2012-06-26 Yale University Methods of treating cancer and other conditions or disease states using LFMAU and LDT
US7951788B2 (en) 2005-12-02 2011-05-31 Yale University Method of treating cancer and other conditions or disease states using L-cytosine nucleoside analogs
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
CN110655507A (en) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 Preparation method of antineoplastic drug tegafur
CN110655507B (en) * 2018-06-29 2022-10-18 鲁南制药集团股份有限公司 Preparation method of anti-tumor medicine tegafur

Also Published As

Publication number Publication date
JPS525517B2 (en) 1977-02-14

Similar Documents

Publication Publication Date Title
AU476761B2 (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU476714B2 (en)
JPS525517B2 (en)
AU472848B2 (en)
AU466283B2 (en)
AU477823B2 (en)
AU471461B2 (en)
AU477824B2 (en)
AU476873B1 (en)
AR196123Q (en)
BG20202A1 (en)
AU479405A (en)
BG18744A1 (en)
AU480357A (en)
AU479906A (en)
AU479863A (en)
AU479562A (en)
AU479539A (en)
AU479522A (en)
AU479521A (en)